Versatility of aminoglycosides and prospects for their future

Clinical Microbiology Reviews

Volumn 16, Issue 3, 2003, Pages 430-450

  Vakulenko, Sergei B ^a,b   Mobashery, Shahriar ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BUTIROSIN; DIBEKACIN; GENTAMICIN; HYGROMYCIN; ISEPAMICIN; KANAMYCIN A; KANAMYCIN B; LIVIDOMYCIN; MESSENGER RNA; NEOMYCIN; NUCLEOTIDYLTRANSFERASE; PAROMOMYCIN; PHOSPHOTRANSFERASE; RIBOSTAMYCIN; RNA 16S; SISOMICIN; STREPTOMYCIN; TOBRAMYCIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CITROBACTER; DRUG DEGRADATION; DRUG EFFICACY; DRUG STRUCTURE; DRUG UPTAKE; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MORGANELLA; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PROTEUS; PSEUDOMONAS; REVIEW; SALMONELLA; SERRATIA; SHIGELLA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ACETYLTRANSFERASES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; NUCLEOTIDYLTRANSFERASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

ACINETOBACTER; BACTERIA (MICROORGANISMS); CITROBACTER; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; SALMONELLA; SERRATIA; SHIGELLA; STAPHYLOCOCCUS AUREUS;

EID: 0037770202     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.16.3.430-450.2003     Document Type: Review

References (326)

1. Ainsa, J. A., C. Martin, B. Gicquel, and R. Gomez-Lus. 1996. Characterization of the chromosomal aminoglycoside 2′-N-acetyltransferase gene from Mycobacterium fortuitum. Antimicrob. Agents Chemother. 40:2350-2355.
2. Ainsa, J. A., E. Perez, V. Pelicic, F. X. Berthet, B. Gicquel, and C. Martin. 1997. Aminoglycoside 2′-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2′)-Ic gene from Mycobacterium tuberculosis and the aac(2′)-Id gene from Mycobacterium smegmatis. Mol. Microbiol. 24:431-441.
3. Aires, J. R., T. Kohler, H. Nikaido, and P. Plesiat. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
4. Akova, M., D. Gur, D. M. Livermore, T. Kocagoz, and H. E. Akalin. 1999. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob. Agents Chemother. 43:1298-1300.
5. Allmansberger, R., B. Brau, and W. Piepersberg. 1985. Genes for gentamicin-(3)-N-acetyl-transferases III and IV. II. Nucleotide sequences of three AAC(3)-III genes and evolutionary aspects. Mol. Gen. Genet. 198:514-520.
6. Allsop, A. E. 1998. New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. Curr. Opin. Microbiol. 1:530-534.
7. Aoki, Y. 1994. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn. J. Antibiot. 47:640-646.
8. Asbtekar, D., N. Duzgunes, and P. R. Gangadharam. 1991. Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. J. Antimicrob. Chemother. 28:615-617.
9. Azucena, E., I. Grapsas, and S. Mobashery. 1997. Properties of a bifunctional bacterial antibiotic resistance enzyme that catalyzes ATP-dependent 2″-phosphorylation and acetyl coenzyme A-dependent 6′-acetylation of aminoglycosides. J. Am. Chem. Soc. 119:2317-2318.
10. Azucena, E., and S. Mobashery. 2001. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. Drug Resist. Update 4:106-117.
11. Baker, C. N., D. G. Hollis, and C. Thornsberry. 1985. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Microbiol. 22:212-215.
12. Ban, N., P. Nissen, J. Hansen, P. B. Moore, and T. A. Steitz. 2000. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 289:905-920.
13. Barg, N. L. 1988. Construction of a probe for the aminoglycoside 3-V-acetyltransferase gene and detection of the gene among endemic clinical isolates. Antimicrob. Agents Chemother. 32:1834-1838.
14. Barza, M., M. Stuart, and F. Szoka, Jr. 1987. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Investig. Ophthalmol. Vis. Sci. 28:893-900.
15. Beaber, J. W., B. Hochhut, and M. K. Waldor. 2002. Genomic and functional analyses of SXT, an integrating antibiotic resistance gene transfer element derived from Vibrio cholerae. J. Bacteriol. 184:4259-4269.
16. Beck, E., G. Ludwig, E. A. Auerswald, B. Reiss, and H. Schaller. 1982. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 19:327-336.
17. Begg, E. J., B. A. Peddie, S. T. Chambers, and D. R. Boswell. 1992. Comparison of gentamicin dosing regimens using an in-vitro model. J. Antimicrob. Chemother. 29:427-433.
18. Belgian Isepamicin Multicentre Study Group. 2001. Comparative in vitro activity of isepamicin and other antibiotics against Gram-negative bacilli from intensive care units in Belgium. Acta Clin. Belg. 56:307-315.
19. Bengtsson, S., S. Bernander, J. E. Brorson, K. Dornbusch, A. Forsgren, H. Hallander, C. Henning, S. Holm, A. S. Malmborg, and L. Nilsson. 1986. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden, 1980-1984. Scand. J. Infect. Dis. 18:257-263.
20. Berg, T., N. Firth, S. Apisiridej, A. Hettiaratchi, A. Leelaporn, and R. A. Skurray. 1998. Complete nucleotide sequence of pSK41: evolution of staphylococcal conjugative multiresistance plasmids. J. Bacteriol. 180:4350-4359.
21. Biddlecome, S., M. Haas, J. Davies, G. H. Miller, D. F. Rane, and P. J. Daniels. 1976. Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob. Agents Chemother. 9:951-955.
22. Bissonnette, L., and P. H. Roy. 1992. Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria. J. Bacteriol. 174:1248-1257.
23. Boerlin, P., A. P. Burnens, J. Frey, P. Kuhnert, and J. Nicolet. 2001. Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. Vet. Microbiol. 79:155-169.
24. Boltner, D., C. MacMahon, J. T. Pembroke, P. Strike, and A. M. Osborn. 2002. R391: a conjugative integrating mosaic comprised of phage, plasmid, and transposon elements. J. Bacteriol. 184:5158-5169.
25. Bouadloun, F., D. Donner, and C. G. Kurland. 1983. Codon-specific missense errors in vivo. EMBO J. 2:1351-1356.
26. Boyd, D., A. Cloeckaert, E. Chaslus-Dancla, and M. R. Mulvey. 2002. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob. Agents Chemother. 46:1714-1722.
27. Brodersen, D. E., W. M. Clemons, Jr., A. P. Carter, R. J. Morgan-Warren, B. T. Wimberly, and V. Ramakrishnan. 2000. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103:1143-1154.
28. Brodersen, D. E., W. M. Clemons, Jr., A. P. Carter, B. T. Wimberly, and V. Ramakrishnan. 2002. Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. J. Mol. Biol. 316:725-768.
29. Brumfitt, W., A. Percival, and D. A. Leigh. 1967. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet 1:1289-1293.
30. Bryan, L. E. 1984. Aminoglycoside resistance, p. 241-277. In L. E. Bryan (ed.), Antimicrobial drug resistance. Academic Press, Orlando, Fla.
31. Bryan, L. E., S. K. Kowand, and H. M. van den Elzen. 1979. Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob. Agents Chemother. 15:7-13.
32. Bryan, L. E., and H. M. van den Elzen. 1977. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob. Agents Chemother. 12:163-177.
33. Bulger, R. J. 1967. Antibiotic combination in staphylococcal infections. Br. Med. J. 4:805.
34. Bulger, R. J. 1967. In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. Lancet 1:17-19.
35. Bundtzen, R. W., A. U. Gerber, D. L. Cohn, and W. A. Craig. 1981. Postantibiotic suppression of bacterial growth. Rev. Infect. Dis. 3:28-37.
36. Bunny, K. L., R. M. Hall, and H. W. Stokes. 1995. New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301. Antimicrob. Agents Chemother. 39:686-693.
37. Burk, D., and A. Berghuis. 2002. Protein kinase inhibitors and antibiotic resistance. Pharmacol. Ther. 93:283-292.
38. Bush, K., and S. Mobashery. 1998. How β-lactamases have driven pharmaceutical drug discovery: from mechanistic knowledge to clinical circumvention, p. 71-98. In B. P. Rosen and S. Mobashery (ed.), Resolving the antibiotic paradox. Kluwer Akademic/Plenum Publishers, New York, N.Y.
39. Calderwood, S. A., C. Wennersten, R. C. Moellering, Jr., L. J. Kunz, and D. J. Krogstad. 1977. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin. Antimicrob. Agents Chemother. 12:401-405.
40. Calderwood, S. B., C. Wennersten, and R. C. Moellering, Jr. 1981. Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4′-deoxy-6′-N-methylamikacin. Antimicrob. Agents Chemother. 19:549-555.
41. Cameron, F. H., D. J. Groot Obbink, V. P. Ackerman, and R. M. Hall. 1986. Nucleotide sequence of the AAD(2″) aminoglycoside adenylyltransferase determinant aadB. Evolutionary relationship of this region with those surrounding aadA in R538-1 and dhfrII in R388. Nucleic Acids Res. 14:8625-8635.
42. Capela, D., F. Barloy-Hubler, J. Gouzy, G. Bothe, F. Ampe, J. Batut, P. Boistard, A. Becker, M. Boutry, E. Cadieu, S. Dreano, S. Gloux, T. Godrie, A. Goffeau, D. Kahn, E. Kiss, V. Lelaure, D. Masuy, T. Pohl, D. Portetelle, A. Puhler, B. Purnelle, U. Ramsperger, C. Renard, P. Thebault, M. Vandenbol, S. Weidner, and F. Galibert. 2001. Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021. Proc. Natl. Acad. Sci. USA 98:9877-9882.
43. Carattoli, A., F. Tosini, W. P. Giles, M. E. Rupp, S. H. Hinrichs, F. J. Angulo, T. J. Barrett, and P. D. Fey. 2002. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46:1269-1272.
44. Carlier, C., and P. Courvalin. 1990. Emergence of 4′,4″-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob. Agents Chemother. 34:1565-1569.
45. Carter, A. P., W. M. Clemons, D. E. Brodersen, R. J. Morgan-Warren, B. T. Wimberly, and V. Ramakrishnan. 2000. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407:340-348.
46. Centron, D., and P. H. Roy. 1998. Characterization of the 6′-N-aminoglycoside acetyltransferase gene aac(6′)-Iq from the integron of a natural multiresistance plasmid. Antimicrob. Agents Chemother. 42:1506-1508.
47. Centron, D., and P. H. Roy. 2002. Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion. Antimicrob. Agents Chemother. 46:1402-1409.
48. Chaslus-Dancla, E., Y. Glupcznski, G. Gerbaud, M. Lagorce, J. P. Lafont, and P. Courvalin. 1989. Detection of apramycin resistant Enterobacteriaceae in hospital isolates. FEMS Microbiol. Lett. 52:261-265.
49. Chinault, A. C., V. A. Blakesley, E. Roessler, D. G. Willis, C. A. Smith, R. G. Cook, and R. G. Fenwick, Jr. 1986. Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. Plasmid 15:119-131.
50. Chiou, C. S., and A. L. Jones. 1993. Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria. J. Bacteriol. 175:732-740.
51. Chow, J. W. 2000. Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31:586-589.
52. Chow, J. W., V. Kak, I. You, S. J. Kao, J. Petrin, D. B. Clewell, S. A. Lerner, G. H. Miller, and K. J. Shaw. 2001. Aminoglycoside resistance genes aph(2″)-Ib and aac(6′)-Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob. Agents Chemother. 45:2691-2694.
53. Chow, J. W., M. J. Zervos, S. A. Lerner, L. A. Thal, S. M. Donabedian, D. D. Jaworski, S. Tsai, K. J. Shaw, and D. B. Clewell. 1997. A novel gentamicin resistance gene in Enterococcus. Antimicrob. Agents Chemother. 41:511-514.
54. Clark, N. C., O. Olsvik, J. M. Swenson, C. A. Spiegel, and F. C. Tenover. 1999. Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis. Antimicrob. Agents Chemother. 43:157-160.
55. Cohn, D. L., F. Bustreo, and M. C. Raviglione. 1997. Drug-resistant tuberculosis: review of the worldwide situation and the W.H.O./IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin. Infect. Dis. 24(Suppl. 1):S121-S130.
56. Comber, K. R., M. J. Basker, C. D. Osborne, and R. Sutherland. 1977. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo. Antimicrob. Agents Chemother. 11:956-964.
57. Cordeiro, J. C., A. O. Reis, E. A. Miranda, and H. S. Sader. 2001. In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals. Braz. J. Infect. Dis. 5:130-135.
58. Costa, Y., M. Galimand, R. Leclercq, J. Duval, and P. Courvalin. 1993. Characterization of the chromosomal aac(6′)-Ii gene specific for Enterococcus faecium. Antimicrob. Agents Chemother. 37:1896-1903.
59. Couch, L. A. 2001. Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. Chest 120(Suppl.):114S-117S.
60. Courvalin, P., and M. Fiandt. 1980. Aminoglycoside-modifying enzymes of Staphylococcus aureus: expression in Escherichia coli. Gene 9:247-269.
61. Craig, W. A., and S. C. Ebert. 1990. Killing and regrowth of bacteria in vitro: a review. Scand. J. Infect. Dis. 74:63-70.
62. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, Md.
63. Craig, W. A., and B. Vogelman. 1987. The postantibiotic effect. Ann. Intern. Med. 106:900-902.
64. Cundliffe, E. 1989. How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 43:207-233.
65. Daigle, D. M., G. A. McKay, and G. D. Wright. 1997. Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors. J. Biol. Chem. 272:24755-24758.
66. Dalsgaard, A., A. Forslund, D. Sandvang, L. Arntzen, and K. Keddy. 2001. Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. J. Antimicrob. Chemother. 48:827-838.
67. Dalsgaard, A., A. Forslund, O. Serichantalergs, and D. Sandvang. 2000. Distribution and content of class I integrons in different Vibrio cholerae O-serotype strains isolated in Thailand. Antimicrob. Agents Chemother. 44:1315-1321.
68. Dalsgaard, A., A. Forslund, N. V. Tam, D. X. Vinh, and P. D. Cam. 1999. Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996. J. Clin. Microbiol. 37:734-741.
69. Damper, P. D., and W. Epstein. 1981. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20:803-808.
70. Davies, J., and D. I. Smith. 1978. Plasmid-determined resistance to antimicrobial agents. Annu. Rev. Microbiol. 32:469-518.
71. Davis, B. D. 1987. Mechanism of bactericidal action of aminoglycosides. Microbiol. Rev. 51:341-350.
72. Distler, J., A. Ebert, K. Mansouri, K. Pissowotzki, M. Stockmann, and W. Piepersberg. 1987. Gene cluster for streptomycin biosynthesis in Streptomyces griseus: nucleotide sequence of three genes and analysis of transcriptional activity. Nucleic Acids Res. 15:8041-8056.
73. Dixon, L. G., W. L. Albritton, and P. J. Willson. 1994. An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. Plasmid 32:228-232.
74. Dornbusch, K. 1987. In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Study Group on Antibiotic Resistance. Eur. J. Clin. Microbiol. 6:378-385.
75. Dornbusch, K., S. Bengtsson, J. E. Brorson, H. Fritz, C. Henning, G. Kronvall, P. Larsson, A. S. Malmborg, M. Thore, and A. Tarnvik. 1988. Susceptibility to β-lactam antibiotics and gentamicin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study. Scand. J. Infect. Dis. 20:641-647.
76. Dornbusch, K., G. H. Miller, R. S. Hare, and K. J. Shaw. 1990. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The European Study Group on Antibiotic Resistance. J. Antimicrob. Chemother. 26:131-144.
77. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
78. Dubois, V., L. Poirel, C. Marie, C. Arpin, P. Nordmann, and C. Quentin. 2002. Molecular characterization of a novel class 1 integron containing bla (GES-1) and a fused product of aac3-Ib/aac6′-Ib′ gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:638-645.
79. Ebert, S. C., and W. A. Craig. 1990. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. Infect. Control Hosp. Epidemiol. 11:319-326.
80. Eliopoulos, G. M., and C. T. Eliopoulos. 1988. Antibiotic combinations: should they be tested? Clin. Microbiol. Rev. 1:139-156.
81. Eliopoulos, G. M., B. F. Farber, B. E. Murray, C. Wennersten, and R. C. Moellering, Jr. 1984. Ribosomal resistance of clinical enterococcal isolates to streptomycin. Antimicrob. Agents Chemother. 25:398-399.
82. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, Md.
83. Enderlin, G., L. Morales, R. F. Jacobs, and J. T. Cross. 1994. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin. Infect. Dis. 19:42-47.
84. Falbo, V., A. Carattoli, F. Tosini, C. Pezzella, A. M. Dionisi, and I. Luzzi. 1999. Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy. Antimicrob. Agents Chemother. 43:693-696.
85. Fantin, B., S. Ebert, J. Leggett, B. Vogelman, and W. A. Craig. 1991. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. J. Antimicrob. Chemother. 27:829-836.
86. Ferretti, J. J., K. S. Gilmore, and P. Courvalin. 1986. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J. Bacteriol. 167:631-638.
87. Fling, M. E., J. Kopf, and C. Richards. 1985. Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3″-(9)-O-nucleotidyltransferase. Nucleic Acids Res. 13:7095-7106.
88. Fountain, M.W., S. J. Weiss, A. G. Fountain, A. Shen, and R. P. Lenk. 1985. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. J. Infect. Dis. 152:529-535.
89. Fourmy, D., M. I. Recht, S. C. Blanchard, and J. D. Puglisi. 1996. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371.
90. Fourmy, D., M. I. Recht, and J. D. Puglisi. 1998. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J. Mol. Biol. 277:347-362.
91. Fourmy, D., S. Yoshizawa, and J. D. Puglisi. 1998. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J. Mol. Biol. 277:333-345.
92. Frana, T. S., S. A. Carlson, and R. W. Griffith. 2001. Relative distribution and conservation of genes encoding aminoglycoside-modifying enzymes in Salmonella enterica serotype Typhimurium phage type DT104. Appl. Environ. Microbiol. 67:445-448.
93. Franklin, K., and A. J. Clarke. 2001. Overexpression and characterization of the chromosomal aminoglycoside 2′-N-acetyltransferase of Providencia stuartii. Antimicrob. Agents Chemother. 45:2238-2244.
94. Frean, J. A., L. Arntzen, T. Capper, A. Bryskier, and K. P. Klugman. 1996. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob. Agents Chemother. 40:2646-2647.
95. Freeman, C. D., D. P. Nicolau, P. P. Belliveau, and C. H. Nightingale. 1997. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J. Antimicrob. Chemother. 39:677-686.
96. Gales, A. C., R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal. 2001. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SEN-TRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S146-S155.
97. Gangadharam, P. R., D. R. Ashtekar, D. L. Flasher, and N. Duzgunes. 1995. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob. Agents Chemother. 39:725-730.
98. Gates, C. A., and D. B. Northrop. 1988. Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2″-I in support of a Theorell-Chance kinetic mechanism. Biochemistry 27:3826-3833.
99. Gates, C. A., and D. B. Northrop. 1988. Determination of the rate-limiting segment of aminoglycoside nucleotidyltransferase 2″-1 by pH and viscosity-dependent kinetics. Biochemistry 27:3834-3842.
100. Gates, C. A., and D. B. Northrop. 1988. Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2″-I. Biochemistry 27:3820-3825.
101. Gilbert, D. N. 2000. Aminoglycosides, p. 307-336. In G. E. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, vol. 1. Churchill Livingstone, New York, N.Y.
102. Gilbert, D. N. 1991. Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35:399-405.
103. Gillespie, S. H. 2002. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 46:267-274.
104. Graham, J. C., and F. K. Gould. 2002. Role of aminoglycosides in the treatment of bacterial endocarditis. J. Antimicrob. Chemother. 49:437-444.
105. Gravel, M., P. Melancon, and L. Brakier-Gingras. 1987. Cross-linking of streptomycin to the 16S ribosomal RNA of Escherichia coli. Biochemistry 26:6227-6232.
106. Gray, G. S., and W. M. Fitch. 1983. Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. Mol. Biol. Evol. 1:57-66.
107. Green, R., and H. F. Noller. 1997. Ribosomes and translation. Annu. Rev. Biochem. 66:679-716.
108. Gritz, L., and J. Davies. 1983. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 25:179-188.
109. Hachler, H., P. Santanam, and F. H. Kayser. 1996. Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph(3′)-IIb, in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:1254-1256.
110. Haddad, J., L. P. Kotra, B. Llano-Sotelo, C. Kim, E. F. Azucena, Jr., M. Liu, S. B. Vakulenko, C. S. Chow, and S. Mobashery. 2002. Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc. 124:3229-3237.
111. Haddad, J., L. P. Kotra, and S. Mobashery. 2001. Aminoglycoside antibiotics: structures and mechanism of action, p. 307-351. In G. Wang and C. Bertozzi (ed.), Glycochemistry: principles, synthesis, and applications. Marcel Dekker, Inc., New York, N.Y.
112. Haddad, J., M. Z. Liu, and S. Mobashery. 2001. Methodologies in syntheses of aminoglycoside antibiotics, p. 353-424. In G. Wang and C. Bertozzi (ed.), Glycochemistry: principles, synthesis, and applications. Marcel Dekker, Inc., New York, N.Y.
113. Hamilton-Miller, J. M., and S. Shah. 1995. Activity of the semisynthetic kanamycin B derivative arbekacin against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 35:865-868.
114. Hancock, R. E. 1984. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38:237-264.
115. Haney, S. A., L. E. Alksne, P. M. Dunman, E. Murphy, and S. J. Projan. 2002. Genomics in anti-infective drug discovery - getting to endgame. Curr. Pharm. Des. 8:1099-1118.
116. Hannecart-Pokorni, E., F. Depuydt, L. de wit, E. van Bossuyt, J. Content, and R. Vanhoof. 1997. Characterization of the 6′-N-aminoglycoside acetyltransferase gene aac(6′)-Il associated with a sull-type integron. Antimicrob. Agents Chemother. 41:314-318.
117. Harms, J., F. Schluenzen, R. Zarivach, A. Bashan, S. Gat, I. Agmon, H. Bartels, F. Franceschi, and A. Yonath. 2001. High resolution structure of the large ribosomal subunit from a mesophilic eubacterium. Cell 107:679-688.
118. Hayashi, I., M. Inoue, and H. Hashimoto. 1994. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drug. Exp. Clin. Res. 20:225-232.
119. Hedges, R. W., and K. P. Shannon. 1984. Resistance to apramycin in Escherichia coli isolated from animals: detection of a novel aminoglycoside-modifying enzyme. J. Gen. Microbiol. 130:473-482.
120. Hegde, S. S., F. Javid-Majd, and J. S. Blanchard. 2001. Overexpression and mechanistic analysis of chromosomally encoded aminoglycoside 2′-N-acetyltransferase (AAC(2′)-Ic) from Mycobacterium tuberculosis. J. Biol. Chem. 276:45876-45881.
121. Heinzel, P., O. Werbitzky, J. Distler, and W. Piepersberg. 1988. A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3″-phosphotransferase. Relationships between antibiotic and protein kinases. Arch. Microbiol. 150:184-192.
122. Heinzl, B., E. Eber, B. Oberwaldner, G. Haas, and M. S. Zach. 2002. Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study. Pediatr. Pulmonol. 33:32-37.
123. Herbert, C. J., M. Sarwar, S. S. Ner, I. G. Giles, and M. Akhtar. 1986. Sequence and interspecies transfer of an aminoglycoside phosphotransferase gene (APH) of Bacillus circulans. Self-defence mechanism in antibiotic-producing organisms. Biochem. J. 233:383-393.
124. Hessen, M. T., P. G. Pitsakis, and M. E. Levison. 1989. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo. Antimicrob. Agents Chemother. 33:608-611.
125. Hiramatsu, K. 1998. Vancomycin resistance in staphylococci. Drug Resist. Update 1:135-150.
126. Hochhut, B., Y. Lotfi, D. Mazel, S. M. Faruque, R. Woodgate, and M. K. Waldor. 2001. Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1 SXT constins. Antimicrob. Agents Chemother. 45:2991-3000.
127. Hollingshead, S., and D. Vapnek. 1985. Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid 13:17-30.
128. Hon, W. C., G. A. McKay, P. R. Thompson, R. M. Sweet, D. S. Yang, G. D. Wright, and A. M. Berghuis. 1997. Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases. Cell 89:887-895.
129. Hopfield, J. J. 1974. Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proc. Natl. Acad. Sci. USA 71:4135-4139.
130. Hoshiko, S., C. Nojiri, K. Matsunaga, K. Katsumata, E. Satoh, and K. Nagaoka. 1988. Nucleotide sequence of the ribostamycin phosphotransferase gene and of its control region in Streptomyces ribosidificus. Gene 68:285-296.
131. Hubner, J., D. Hartung, A. Kropec, and F. D. Daschner. 1991. Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria. Infection 19:186-189.
132. Hughes, W. T., D. Armstrong, G. P. Bodey, E. J. Bow, A. E. Brown, T. Calandra, R. Feld, P. A. Pizzo, K. V. Rolston, J. L. Shenep, and L. S. Young. 2002. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34:730-751.
133. Hughes, W. T., D. Armstrong, G. P. Bodey, A. E. Brown, J. E. Edwards, R. Feld, P. Pizzo, K. V. Rolston, J., L. Shenep, and L. S. Young. 1997. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. I. Clin. Infect. Dis. 25:551-573.
134. Iannini, P. B., J. Ehret, and T. C. Eickhoff. 1976. Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci. Antimicrob. Agents Chemother. 9:448-451.
135. Ida, T., R. Okamoto, M. Nonoyama, K. Irinoda, M. Kurazono, and M. Inoue. 2002. Antagonism between aminoglycosides and β-lactams in a methicillin-resistant Staphylococcus aureus isolate involves induction of an aminoglycoside-modifying enzyme. Antimicrob. Agents Chemother. 46:1516-1521.
136. Ida, T., R. Okamoto, C. Shimauchi, T. Okubo, A. Kuga, and M. Inoue. 2001. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J. Clin. Microbiol. 39:3115-3121.
137. Inoue, M., M. Nonoyama, R. Okamoto, and T. Ida. 1994. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. Drug. Exp. Clin. Res. 20:233-239.
138. Ito, T., Y. Katayama, and K. Hiramatsu. 1999. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob. Agents Chemother. 43:1449-1458.
139. Jacoby, G. A., M. J. Blaser, P. Santanam, H. Hachler, F. H. Kayser, R. S. Hare, and G. H. Miller. 1990. Appearance of amikacin and tobramycin resistance due to 4′-aminoglycoside nucleotidyltransferase [ANT(4′)-II] in gram-negative pathogens. Antimicrob. Agents Chemother. 34:2381-2386.
140. Kak, V., S. M. Donabedian, M. J. Zervos, R. Kariyama, H. Kumon, and J. W. Chow. 2000. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance. Antimicrob. Agents Chemother. 44:2545-2546.
141. Kao, S. J., I. You, D. B. Clewell, S. M. Donabedian, M. J. Zervos, J. Petrin, K. J. Shaw, and J. W. Chow. 2000. Detection of the high-level aminoglycoside resistance gene aph(2″)-Ib in Enterococcus faecium. Antimicrob. Agents Chemother. 44:2876-2879.
142. Karimi, R., and M. Ehrenberg. 1994. Dissociation rate of cognate peptidyl-tRNA from the A-site of hyper-accurate and error-prone ribosomes. Eur. J. Biochem. 226:355-360.
143. Karimi, R., and M. Ehrenberg. 1996. Dissociation rates of peptidyl-tRNA from the P-site of E. coli ribosomes. EMBO J. 15:1149-1154.
144. Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, and D. J. Hoban. 1994. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. J. Antimicrob. Chemother. 33:937-947.
145. Kehrenberg, C., and S. Schwarz. 2002. Nucleotide sequence and organization of plasmid pMVSCS1 from Mannheimia varigena: identification of a multiresistance gene cluster. J. Antimicrob. Chemother. 49:383-386.
146. Kim, E. H., and T. Aoki. 1994. The transposon-like structure of IS26 - tetracycline and kanamycin resistance determinant derived from transferable R plasmid of fish pathogen Pasteurella piscicida. Microbiol. Immunol. 38:31-38.
147. Klastersky, J., J. Beumer, and D. Daneau. 1972. Susceptibility of Pseudomonas aeruginosa to combinations of antibiotics. Pathol. Biol. 20:643-647.
148. Klastersky, J., R. Cappel, G. Swings, and L. Vandenborre. 1971. Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations. Am. J. Med. Sci. 262:283-290.
149. Kobayashi, N., M. Alam, Y. Nishimoto, S. Urasawa, N. Uehara, and N. Watanabe. 2001. Distribution of aminoglycoside resistance genes in recent clinical isolates of Enterococcus faecalis, Enterococcus faecium and Enterococcus avium. Epidemiol. Infect. 126:197-204.
150. Korzenjowski, O. M., C. Wennersten, R. C. Moellering, Jr., and M. A. Sande. 1978. Penicillin-netilmicin synergism against Streptococcus faecalis. Antimicrob. Agents Chemother. 13:430-434.
151. Kotra, L. P., J. Haddad, and S. Mobashery. 2000 Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44:3249-3256.
152. Kotra, L. P., S. Vakulenko, and S. Mobashery. 2000. From genes to sequences to antibiotics: prospects for future developments from microbial genomics. Microbes Infect. 2:651-658.
153. Kropec, A., S. Lemmen, M. Wursthorn, and F. D. Daschner. 1994. Combination effect of meropenem with aminoglycosides and teicoplanin on Pseudomonas and enterococci. Infection 22:306-308.
154. L'Abee-Lund, T. M., and H. Sorum. 2000. Functional Tn5393-like transposon in the R plasmid pRAS2 from the fish pathogen Aeromonas salmonicida subspecies salmonicida isolated in Norway. Appl. Environ. Microbiol. 66:5533-5535.
155. Lacey, R. W., and I. Chopra. 1972. Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J. Gen. Microbiol. 73:175-180.
156. Lambert, T., G. Gerbaud, P. Bouvet, J. F. Vieu, and P. Courvalin. 1990. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp. Antimicrob. Agents Chemother. 34:1244-1248.
157. Lambert, T., G. Gerbaud, and P. Courvalin. 1994. Characterization of the chromosomal aac(6′)-Ij gene of Acinetobacter sp. strain 13 and the aac(6′)-Ih plasmid gene of Acinetobacter baumannii. Antimicrob. Agents Chemother. 38:1883-1889.
158. Lambert, T., G. Gerbaud, and P. Courvalin. 1988. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3′-aminoglycoside phosphotransferase. Antimicrob. Agents Chemother. 32:15-19.
159. Lambert, T., G. Gerbaud, M. Galimand, and P. Courvalin. 1993. Characterization of Acinetobacter haemolyticus aac(6′)-Ig gene encoding an aminoglycoside, 6′-N-acetyltransferase, which modifies amikacin. Antimicrob. Agents Chemother. 37:2093-2100.
160. Lambert, T., M. C. Ploy, and P. Courvalin. 1994. A spontaneous point mutation in the aac(6′)-Ib' gene results in altered substrate specificity of aminoglycoside 6′-N-acetyltransferase of a Pseudomonas fluorescens strain. FEMS Microbiol. Lett. 115:297-304.
161. Lambert, T., M. C. Ploy, F. Denis, and P. Courvalin. 1999. Characterization of the chromosomal aac(6′)-Iz gene of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 43:2366-2371.
162. Leclercq, R., S. Dutka-Malen, A. Brisson-Noel, C. Molinas, E. Derlot, M. Arthur, J. Duval, and P. Courvalin. 1992. Resistance of enterococci to aminoglycosides and glycopeptides. Clin. Infect. Dis. 15:495-501.
163. Lee, K. Y., J. D. Hopkins, and M. Syvanen. 1991. Evolved neomycin phosphotransferase from an isolate of Klebsiella pneumoniae. Mol. Microbiol. 5:2039-2046.
164. Leigh, D. A., K. Bradnock, and J. M. Marriner. 1981. Augmentin (amoxicillin and clavulanic acid) therapy in complicated infections due to β-lactamase-producing bacteria. J. Antimicrob. Chemother. 7:229-236.
165. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
166. Liu, M., J. Haddad, E. Azucena, L. P. Kotra, M. Kirzhner, and S. Mobashery. 2000. Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3′-phosphotransferases. J. Org. Chem. 65:7422-7431.
167. Llano-Sotelo, B., E. F. Azucena, L. P. Kotra, S. Mobashery, and C. S. Chow. 2002. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol. 9:455-463.
168. Lodmell, J. S., and A. E. Dahlberg. 1997. A conformational switch in Escherichia coli 16S ribosomal RNA during decoding of messenger RNA. Science 277:1262-1267.
169. Lovering, A. M., L. O. White, and D. S. Reeves. 1987. AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin. J. Antimicrob. Chemother. 20:803-813.
170. Low, D. E., N. Keller, A. Barth, and R. N. Jones. 2001. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S133-S145.
171. Lyutzkanova, D., J. Distler, and J. Altenbuchner. 1997. A spectinomycin resistance determinant from the spectinomycin producer Streptomyces flavopersicus. Microbiology 143:2135-2143.
172. Macinga, D. R., M. R. Paradise, M. M. Parojcic, and P. N. Rather. 1999. Activation of the 2′-N-acetyltransferase gene [aac(2′)-Ia] in Providencia stuartii by an interaction of AarP with the promoter region. Antimicrob. Agents Chemother. 43:1769-1772.
173. Macinga, D. R., and P. N. Rather. 1999. The chromosomal 2′-N-acetyl-transferase of Providencia stuartii: physiological functions and genetic regulation. Front. Biosci. 4:D132-D140.
174. MacLeod, D. L., and J. F. Prescott. 1988. The use of liposomally entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. Can. J. Vet. Res. 52:445-450.
175. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.
176. Majumdar, S., D. Flasher, D. S. Friend, P. Nassos, D. Yajko, W. K. Hadley, and N. Duzgunes. 1992. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 36:2808-2815.
177. Maness, M. J., G. C. Foster, and P. F. Sparling. 1974. Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae. J. Bacteriol. 120:1293-1299.
178. Martin, N. L., and T. J. Beveridge. 1986. Gentamicin interaction with Pseudomonas aeruginosa cell envelope. Antimicrob. Agents Chemother. 29:1079-1087.
179. Martin, P., E. Jullien, and P. Courvalin. 1988. Nucleotide sequence of Acinetobacter baumannii aphA-6 gene: evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes. Mol. Microbiol. 2:615-625.
180. Matsumura, M., Y. Katakura, T. Imanaka, and S. Alba. 1984. Enzymatic and nucleotide sequence studies of a kanamycin-inactivating enzyme encoded by a plasmid from thermophilic bacilli in comparison with that encoded by plasmid pUB110. J. Bacteriol. 160:413-420.
181. Maurin, M., and D. Raoult. 2001. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob. Agents Chemother. 45:2977-2986.
182. Mazel, D., B. Dychinco, V. A. Webb, and J. Davies. 2000. Antibiotic resistance in the ECOR collection: integrons and identification of a novel aad gene. Antimicrob. Agents Chemother. 44:1568-1574.
183. McDonald, P. J., W. A. Craig, and C. M. Kunin. 1977. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135:217-223.
184. McKay, G. A., and G. D. Wright. 1995. Kinetic mechanism of aminoglycoside phosphotransferase type IIIa. Evidence for a Theorell-Chance mechanism. J. Biol. Chem. 270:24686-24692.
185. Mehta, R., and W. S. Champney. 2002. 30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob. Agents Chemother. 46:1546-1549.
186. Melancon, P., C. Lemieux, and L. Brakier-Gingras. 1988. A mutation in the 530 loop of Escherichia coli 16S ribosomal RNA causes resistance to streptomycin. Nucleic Acids Res. 16:9631-9639.
187. Miller, G., F. Sabatelli, R. Hare, and J. Waitz. 1980. Survey of aminoglycoside resistance patterns. Dev. Ind. Microbiol. 8:91-104.
188. Miller, G. H., F. J. Sabatelli, R. S. Hare, Y. Glupczynski, P. Mackey, D. Shlaes, K. Shimizu, and K. J. Shaw. 1997. The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin. Infect. Dis. 24(Suppl. 1):S46-S62.
189. Miller, G. H., F. J. Sabatelli, L. Naples, R. S. Hare, and K. J. Shaw. 1995. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin - a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. J. Chemother. 7(Suppl. 2):31-44.
190. Miller, M. H., S. C. Edberg, L. J. Mandel, C. F. Behar, and N. H. Steigbigel. 1980. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18:722-729.
191. Moazed, D., and H. F. Noller. 1987. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389-394.
192. Moellering, R. C., Jr. 1991. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. The Garrod Lecture. J. Antimicrob. Chemother. 28:1-12.
193. Moellering, R. C., Jr. 1983. In vitro antibacterial activity of the aminoglycoside antibiotics. Rev. Infect. Dis. 5(Suppl.):S212-S232.
194. 14C-labeled streptomycin by enterococci. J. Clin. Investig. 50:2580-2584.
195. Moir, D. T., K. J. Shaw, R. S. Hare, and G. F. Vovis. 1999. Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. 43:439-446.
196. Montandon, P. E., R. Wagner, and E. Stutz. 1986. E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant. EMBO J. 5:3705-3708.
197. Moore, R. A., D. DeShazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
198. Moore, R. D., P. S. Lietman, and C. R. Smith. 1987. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155:93-99.
199. Morabito, S., R. Tozzoli, A. Caprioli, H. Karch, and A. Carattoli. 2002. Detection and characterization of class 1 integrons in enterohemorrhagic Escherichia coli. Microb. Drug Resist. 8:85-91.
200. Mortensen, J. E., D. G. Moore, J. E. Clarridge, and E. J. Young. 1986. Antimicrobial susceptibility of clinical isolates of Brucella. Diagn. Microbiol. Infect. Dis. 5:163-169.
201. Moss, R. B. 2001. Administration of aerosolized antibiotics in cystic fibrosis patients. Chest 120:107S-113S.
202. Moss, R. B. 2002. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest 121:55-63.
203. Muller, R. E., T. Ano, T. Imanaka, and S. Aiba. 1986. Complete nucleotide sequences of Bacillus plasmids pUB110dB, pRBH1 and its copy mutants. Mol. Gen. Genet. 202:169-171.
204. Murata, T., M. Ohnishi, T. Ara, J. Kaneko, C. G. Han, Y. F. Li, K. Takashima, H. Nojima, K. Nakayama, A. Kaji, Y. Kamio, T. Miki, H. Mori, E. Ohtsubo, Y. Terawaki, and T. Hayashi. 2002. Complete nucleotide sequence of plasmid Rts1: implications for evolution of large plasmid genomes. J. Bacteriol. 184:3194-3202.
205. Murphy, E. 1985. Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3″)(9). Mol. Gen. Genet. 200:33-39.
206. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
207. Naas, T., L. Poirel, and P. Nordmann. 1999. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa. Biochim. Biophys. Acta 1489:445-451.
208. Naas, T., W. Sougakoff, A. Casetta, and P. Nordmann. 1998. Molecular characterization of OXA-20, a novel class D β-lactamase, and its integron from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:2074-2083.
209. Nakamura, A., M. Hosoda, T. Kato, Y. Yamada, M. Itoh, K. Kanazawa, and H. Nouda. 2000. Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. J. Antimicrob. Chemother. 46:901-904.
210. Nesvera, J., J. Hochmannova, and M. Patek. 1998. An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum. FEMS Microbiol. Lett. 169:391-395.
211. Nicolau, D. P., and R. Quintiliani, Jr. 1999. Aminoglycosides, p. 621-638. In V. L. Yu, T. C. Merigan, Jr., and S. L. Barriere (ed.), Antimicrobial therapy and vaccines. Williams and Wilkins, Baltimore, Md.
212. Ninio, J. 1975. Kinetic amplification of enzyme discrimination. Biochimie 57:587-595.
213. Ogle, J. M., D. E. Brodersen, W. M. Clemons, Jr., M. J. Tarry, A. P. Carter, and V. Ramakrishnan. 2001. Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292:897-902.
214. Ohmiya, K., T. Tanaka, N. Noguchi, K. O'Hara, and M. Kono. 1989. Nucleotide sequence of the chromosomal gene coding for the aminoglycoside 6-adenylyltransferase from Bacillus subtilis Marburg 168. Gene 78:377-378.
215. Oka, A., H. Sugisaki, and M. Takanami. 1981. Nucleotide sequence of the kanamycin resistance transposon Tn903. J. Mol. Biol. 147:217-226.
216. Ouellette, M., G. Gerbaud, T. Lambert, and P. Courvalin. 1987. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 31:1021-1026.
217. Ounissi, H., E. Derlot, C. Carlier, and P. Courvalin. 1990. Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci. Antimicrob. Agents Chemother. 34:2164-2168.
218. Over, U., D. Gur, S. Unal, and G. H. Miller. 2001. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin. Microbiol. Infect. 7:470-478.
219. Owens, R. C., Jr., M. A. Banevicius, D. P. Nicolau, C. H. Nightingale, and R. Quintiliani. 1997. In vitro synergistic activities of tobramycin and selected β-lactams against 75 gram-negative clinical isolates. Antimicrob. Agents Chemother. 41:2586-2588.
220. Papadopoulou, B., and P. Courvalin. 1988. Dispersal in Campylobacter spp. of aphA-3, a kanamycin resistance determinant from gram-positive cocci. Antimicrob. Agents Chemother. 32:945-948.
221. Partridge, S. R., C. M. Collis, and R. M. Hall. 2002. Class 1 integron containing a new gene cassette, aad,410, associated with TnI404 from R151. Antimicrob. Agents Chemother. 46:2400-2408.
222. Paulsen, I. T., N. Firth, and R. A. Skurray. 1997. Resistance to antimicrobial agents other than β-lactams., p. 175-212. In K. B. Krossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, New York, N.Y.
223. Payie, K. G., and A. J. Clarke. 1997. Characterization of gentamicin 2′-N-′acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan. J. Bacteriol. 179:4106-4114.
224. Payie, K. G., P. N. Rather, and A. J. Clarke. 1995. Contribution of gentamicin 2′-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii. J. Bacteriol. 177:4303-4310.
225. Payie, K. G., H. Strating, and A. J. Clarke. 1996. The role of O-acetylation in the metabolism of peptidoglycan in Providencia stuartii. Microb. Drug Resist. 2:135-140.
226. Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
227. Peyman, G. A., H. C. Charles, K. R. Liu, B. Khoobehi, and M. Niesman. 1988. Intravitreal liposome-encapsulated drugs: a preliminary human report. Int. Ophthalmol. 12:175-182.
228. Pfaller, M. A., R. N. Jones, G. V. Doern, and K. Kugler. 1998. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 42:1762-1770.
229. Ploy, M. C., F. Denis, P. Courvalin, and T. Lambert. 2000. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob. Agents Chemother. 44:2684-2688.
230. Poirel, L., T. Lambert, S. Turkoglu, E. Ronco, J. Gaillard, and P. Nordmann. 2001. Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the bla (VIM-2) carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45:546-552.
231. Prammananan, T., P. Sander, B. A. Brown, K. Frischkorn, G. O. Onyi, Y. Zhang, E. C. Bottger, and R. J. Wallace, Jr. 1998. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177:1573-1581.
232. Preston, K. E., M. A. Kacica, R. J. Limberger, W. A. Archinal, and R. A. Venezia. 1997. The resistance and integrase genes of pACM1, a conjugative multiple-resistance plasmid, from Klebsiella oxytoca. Plasmid 37:105-118.
233. Preston, S. L., and L. L. Briceland. 1995. Single daily dosing of aminoglycosides. Pharmacotherapy 15:297-316.
234. Price, C. I., J. W. Horton, and C. R. Baxter. 1992. Liposome delivery of aminoglycosides in burn wounds. Surg. Gynecol. Obstet. 174:414-418.
235. Price, C. I., J. W. Horton, and C. R. Baxter. 1994. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics. Surgery 115:480-487.
236. Price, K. E., P. A. Kresel, L. A. Farchione, S. B. Siskin, and S. A. Karpow. 1981. Epidemiological studies of aminoglycoside resistance in the USA J. Antimicrob. Chemother. 8(Suppl. A):89-105.
237. Projan, S. 2002. New (and not so new) antibacterial targets - from where and when will the novel drugs come? Curr. Opin. Pharmacol. 2:513.
238. Quittner, A. L., and A. Buu. 2002. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr. Pulmonol. 33:269-276.
239. Rather, P. N., P. A. Mann, R. Mierzwa, R. S. Hare, G. H. Miller, and K. J. Shaw. 1993. Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase. Antimicrob. Agents Chemother. 37:2074-2079.
240. Rather, P. N., R. Mierzwa, R. S. Hare, G. H. Miller, and K. J. Shaw. 1992. Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens. Antimicrob. Agents Chemother. 36:2222-2227.
241. Rather, P. N., H. Munayyer, P. A. Mann, R. S. Hare, G. H. Miller, and K. J. Shaw. 1992. Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6′-N-acetyltransferase Ib and IIa proteins. J. Bacteriol. 174:3196-3203.
242. Rather, P. N., E. Orosz, K. J. Shaw, R. Hare, and G. Miller. 1993. Characterization and transcriptional regulation of the 2′-N-acetyltransferase gene from Providencia stuartii. J. Bacteriol. 175:6492-6498.
243. Ratjen, F., G. Doring, and W. H. Nikolaizik. 2001. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 358:983-984.
244. Riccio, M. L., L. Pallecchi, R. Fontana, and G. M. Rossolini. 2001. In70 of plasmid pAX22, a bla (VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45:1249-1253.
245. Rochon-Edouard, S., M. Pestel-Caron, J. F. Lemeland, and F. Caron. 2000. In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 44:3055-3060.
246. Roestamadji, J., and S. Mobashery. 1998. The use of neamine as a molecular template: inactivation of bacterial antibiotic resistance enzyme aminoglycoside 3′-phosphotransferase type IIa. Bioorg. Med. Chem. Lett. 8:3483-3488.
247. Roselle, G. A., R. Bode, B. Hamilton, M. Bibler, R. Sullivan, R. Douce, J. L. Staneck, and W. E. Bullock. 1985. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob. Agents Chemother. 27:291-296.
248. Rosenberg, E. Y., D. Ma, and H. Nikaido. 2000. AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182:1754-1756.
249. Rudant, E., P. Bourlioux, P. Courvalin, and T. Lambert. 1994. Characterization of the aac(6′)-Ik gene of Acinetobacter sp. 6. FEMS Microbiol. Lett. 124:49-54.
250. Ruusala, T., and C. G. Kurland. 1984. Streptomycin preferentially perturbs ribosomal proofreading. Mol. Gen. Genet. 198:100-104.
251. Salauze, D., and J. Davies. 1991. Isolation and characterisation of an aminoglycoside phosphotransferase from neomycin-producing Micromonospora chalcea: comparison with that of Streptomyces fradiae and other producers of 4,6-disubstituted 2-deoxystreptamine antibiotics. J. Antibiot. (Tokyo) 44:1432-1443.
252. Sande, M. A., and K. B. Courtney. 1976. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J. Lab. Clin. Med. 88:118-124.
253. Sandvang, D. 1999. Novel streptomycin and spectinomycin resistance gene as a gene cassette within a class 1 integron isolated from Escherichia coli. Antimicrob. Agents Chemother. 43:3036-3038.
254. Santanam, P., and F. H. Kayser. 1978. Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4′- and 4"-hydroxyl groups of the aminoglycoside antibiotics. J. Antibiot. (Tokyo) 31:343-351.
255. Schatz, A., and S. A. Waksman. 1944. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc. Soc. Exp. Biol. Med. 57:244-248.
256. Schiffelers, R., G. Storm, and I. Bakker-Woudenberg. 2001. Liposome-encapsulated aminoglycosides in preclinical and clinical studies. J. Antimicrob. Chemother. 48:333-344.
257. Schluenzen, F., A. Tocilj, R. Zarivach, J. Harms, M. Gluehmann, D. Janell, A. Bashan, H. Bartels, I. Agmon, F. Franceschi, and A. Yonath. 2000. Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. Cell 102:615-623.
258. Schmidt, F. R., E. J. Nucken, and R. B. Henschke. 1988. Nucleotide sequence analysis of 2″-aminoglycoside nucleotidyl-transferase ANT(2″) from Tn4000: its relationship with AAD(3″) and impact on Tn21 evolution. Mol. Microbiol. 2:709-717.
259. Schmitz, F. J., A. C. Fluit, M. Gondolf, R. Beyrau, E. Lindenlauf, J. Verhoef, H. P. Heinz, and M. E. Jones. 1999. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J. Antimicrob. Chemother. 43:253-259.
260. Schmitz, F. J., J. Verhoef, and A. C. Fluit. 1999. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur. J. Clin. Microbiol. 18:414-421.
261. Scholz, P., V. Haring, B. Wittmann-Liebold, K. Ashman, M. Bagdasarian, and E. Scherzinger. 1989. Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. Gene 75:271-288.
262. Schwocho, L. R., C. P. Schaffner, G. H. Miller, R. S. Hare, and K. J. Shaw. 1995. Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1790-1796.
263. Segal, H., and B. G. Elisha. 1997. Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. FEMS Microbiol. Lett. 153:321-326.
264. Shanson, D. C. 1998. New guidelines for the antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. J. Antimicrob. Chemother. 42:292-296.
265. Shaw, K. J., C. A. Cramer, M. Rizzo, R. Mierzwa, K. Gewain, G. H. Miller, and R. S. Hare. 1989. Isolation, characterization, and DNA sequence analysis of an AAC(6′)-II gene from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 33:2052-2062.
266. Shaw, K. J., R. S. Hare, F. J. Sabatelli, M. Rizzo, C. A. Cramer, L. Naples, S. Kocsi, H. Munayyer, P. Mann, G. H. Miller, et al. 1991. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob. Agents Chemother. 35:2253-2261.
267. Shaw, K. J., H. Munayyer, P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Nucleotide sequence analysis and DNA hybridization studies of the ant(4′)-IIa gene from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:708-714.
268. Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.
269. Shaw, K. J., P. N. Rather, F. J. Sabatelli, P. Mann, H. Munayyer, R. Mierzwa, G. L. Petrikkos, R. S. Hare, G. H. Miller, P. Bennett, et al. 1992. Characterization of the chromosomal aac(6′)-Ic gene from Serratia marcescens. Antimicrob. Agents Chemother. 36:1447-1455.
270. Shimizu, K., T. Kumada, W. C. Hsieh, H. Y. Chung, Y. Chong, R. S. Hare, G. H. Miller, F. J. Sabatelli, and J. Howard. 1985. Comparison of aminoglycoside resistance patterns in Japan, Formosa, Korea, Chile, and the United States. Antimicrob. Agents Chemother. 28:282-288.
271. Sigmund, C. D., M. Ettayebi, and E. A. Morgan. 1984. Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. Nucleic Acids Res. 12:4653-4663.
272. Solera, J. 2000. Treatment of human brucellosis. Leban. Med. J. 48:255-263.
273. Solera, J., J. L. Beato, E. Martinez-Alfaro, J. C. Segura, and E. de Tomas. 2001. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. Clin. Infect. Dis. 32:506-509.
274. Sorokin, A., A. Bolotin, B. Purnelle, H. Hilbert, J. Lauber, A. Dusterhoft, and S. D. Ehrlich. 1997. Sequence of the Bacillus subtilis genome region in the vicinity of the lev operon reveals two new extracytoplasmic function RNA polymerase sigma factors, SigV and SigZ. Microbiology 143:2939-2943.
275. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
276. Sucheck, S. J., A. L. Wong, K. M. Koeller, D. D. Boehr, K.-A. Draker, P. Sears, G. D. Wright, and C.-H. Wong. 2000. Design of bifunctional antibiotics that target bacterial rRNA and inhibit resistance-causing enzymes. J. Am. Chem. Soc. 122:5230-5231.
277. Sugiyama, M., K. Yuasa, M. Z. Bhuiyan, Y. Iwai, N. Masumi, and K. Ueda. 1996. IS43 mec-mediated integration of a bleomycin-resistance gene into the chromosome of a methicillin-resistant Staphylococcus aureus strain isolated in Japan. Appl. Microbiol. Biotechnol. 46:61-66.
278. Sundin, G. W. 2000. Examination of base pair variants of the strA-strB streptomycin resistance genes from bacterial pathogens of humans, animals and plants. J. Antimicrob. Chemother. 46:848-849.
279. Sundin, G. W., and C. L. Bender. 1996. Dissemination of the strA-strB streptomycin-resistance genes among commensal and pathogenic bacteria from humans, animals, and plants. Mol. Ecol. 5:133-143.
280. Sundin, G. W., and C. L. Bender. 1993. Ecological and genetic analysis of copper and streptomycin resistance in Pseudomonas syringae pv. syringae. Appl. Environ. Microbiol. 59:1018-1024.
281. Sundin, G. W., and C. L. Bender. 1995. Expression of the strA-strB streptomycin resistance genes in Pseudomonas syringae and Xanthomonas campestris and characterization of IS6100 in X campestris. Appl. Environ. Microbiol. 61:2891-2897.
282. Suter, T. M., V. K. Viswanathan, and N. P. Cianciotto. 1997. Isolation of a gene encoding a novel spectinomycin phosphotransferase from Legionella pneumophila. Antimicrob. Agents Chemother. 41:1385-1388.
283. Swenson, C. E., K. A. Stewart, J. L. Hammett, W. E. Fitzsimmons, and R. S. Ginsberg. 1990. Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrob. Agents Chemother. 34:235-240.
284. Taber, H. W., J. P. Mueller, P. F. Miller, and A. S. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439-457.
285. Tadakuma, T., N. Ikewaki, T. Yasuda, M. Tsutsumi, S. Salto, and K. Saito. 1985. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrob. Agents Chemother. 28:28-32.
286. Takami, H., K. Nakasone, Y. Takaki, G. Maeno, R. Sasaki, N. Masui, F. Fuji, C. Hirama, Y. Nakamura, N. Ogasawara, S. Kuhara, and K. Horikoshi. 2000. Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Res. 28:4317-4331.
287. Tauch, A., S. Krieft, J. Kalinowski, and A. Puhler. 2000. The 51,409-bp R-plasmid pTP10 from the multiresistant clinical isolate Corynebacterium striatum M82B is composed of DNA segments initially identified in soil bacteria and in plant, animal, and human pathogens. Mol. Gen. Genet. 263:1-11.
288. Taylor, D. E., W. Yan, L. K. Ng, E. K. Manavathu, and P. Courvalin. 1988. Genetic characterization of kanamycin resistance in Campylobacter coli. Ann. Inst. Pasteur Microbiol. 139:665-676.
289. Tenorio, C., M. Zarazaga, C. Martinez, and C. Torres. 2001. Bifunctional enzyme 6′-N-aminoglycoside acetyltransferase-2″-O-aminoglycoside phosphotransferase in Lactobacillus and Pediococcus isolates of animal origin. J. Clin. Microbiol. 39:824-825.
290. Tenover, F. C., and P. M. Elvrum. 1988. Detection of two different kanamycin resistance genes in naturally occurring isolates of Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 32:1170-1173.
291. Tenover, F. C., T. Gilbert, and P. O'Hara. 1989. Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. Plasmid 22.:52-58.
292. Tenover, F. C., K. L. Phillips, T. Gilbert, P. Lockhart, P. J. O'Hara, and J. J. Plorde. 1989. Development of a DNA probe from the deoxyribonucleotide sequence of a 3-N-aminoglycoside acetyltransferase [AAC(3)-I] resistance gene. Antimicrob. Agents Chemother. 33:551-559.
293. The Aminoglycoside Resistance Study Groups. 1995. The most frequently occurring aminoglycoside resistance mechanisms-combined results of surveys in eight regions of the world. J. Chemother. 7(Suppl. 2):17-30.
294. Thompson, C. J., and G. S. Gray. 1983. Nucleotide sequence of a streptomycete aminoglycoside phosphotransferase gene and its relationship to phosphotransferases encoded by resistance plasmids. Proc. Natl. Acad. Sci. USA 80:5190-5194.
295. Thompson, J., P. A. Skeggs, and E. Cundliffe. 1985. Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer. Micromonospora purpurea. Mol. Gen. Genet. 201:168-173.
296. Thungapathra, M., Amita, K. K. Sinha, S. R. Chaudhuri, P. Garg, T. Ramamurthy, G. B. Nair, and A. Ghosh. 2002. Occurrence of antibiotic resistance gene cassettes aac(6′)-1b, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India. Antimicrob. Agents Chemother. 46:2948-2955.
297. Tolmasky, M. E., and J. H. Crosa. 1993. Genetic organization of antibiotic resistance genes (aac(6′)-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. Plasmid 29:31-40.
298. Tosini, F., P. Visca, I. Luzzi, A. M. Dionisi, C. Pezzella, A. Petrucca, and A. Carattoli. 1998. Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 42:3053-3058.
299. Trieu-Cuot, P., and P. Courvalin. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′,5″-aminoglycoside phosphotransferase type III. Gene 23:331-341.
300. Tsai, S. F., M. J. Zervos, D. B. Clewell, S. M. Donabedian, D. F. Sahm, and J. W. Chow. 1998. A new high-level gentamicin resistance gene, aph(2″)-Id, in Enterococcus spp. Antimicrob. Agents Chemother. 42:1229-1232.
301. Ubukata, K., N. Yamashita, A. Gotoh, and M. Konno. 1984. Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 25:754-759.
302. Udo, E. E., and A. A. Dashti. 2000. Detection of genes encoding aminoglycoside-modifying enzymes in staphylococci by polymerase chain reaction and dot blot hybridization. Int. J. Antimicrob. Agents 13:273-279.
303. Umezawa, H., Y. Nishimura, T. Tsuchiya, and S. Umezawa. 1972. Syntheses of 6′-N-methyl-kanamycin and 3′,4′-dideoxy-6′-N-methylkanamycin B active against resistant strains having 6′-N-acetylating enzymes. J. Antibiot. (Tokyo) 25:743-745.
304. Reference deleted
305. Vanhoof, R., E. Hannecart-Pokorni, and J. Content. 1998. Nomenclature of genes encoding aminoglycoside-modifying enzymes. Antimicrob. Agents Chemother. 42:483.
306. Vicens, Q., and E. Westhof. 2001. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure (Cambridge) 9:647-658.
307. Vliegenthart, J. S., P. A. Ketelaar-van Gaalen, and J. A. van de Klundert. 1991. Nucleotide sequence of the aacC3 gene, a gentamicin resistance determinant encoding aminoglycoside-(3)-N-acetyltransferase III expressed in Pseudomonas aeruginosa but not in Escherichia coli. Antimicrob. Agents Chemother. 35:892-897.
308. Vogtli, M., and R. Hutter. 1987. Characterisation of the hydroxystreptomycin phosphotransferase gene (sph) of Streptomyces glaucescens: nucleotide sequence and promoter analysis. Mol. Gen. Genet. 208:195-203.
309. Watanakunakorn, C. 1986. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa. J. Antimicrob. Chemother. 17:91-95.
310. Watanakunakorn, C., and C. Glotzbecker. 1979. In vitro activity of carbenicillin, ticarcillin, aminoglycosides and combinations against Staphylococcus aureus. J. Antimicrob. Chemother. 5:151-158.
311. Werner, G., B. Hildebrandt, and W. Witte. 2001. Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium. Antimicrob. Agents Chemother. 45:3267-3269.
312. Westbrock-Wadman, S., D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu, P. Warrener, L. Y. Nguyen, R. M. Shawar, K. R. Folger, and C. K. Stover. 1999. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983.
313. White, P. A., C. J. McIver, and W. D. Rawlinson. 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob. Agents Chemother. 45:2658-2661.
314. Wilson, D. N., G. Blaha, S. R. Connell, P. V. Ivanov, H. Jenke, U. Stelzl, Y. Teraoka, and K. H. Nierhaus. 2002. Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome. Curr. Protein Peptide Sci. 3:1-53.
315. Wimberly, B. T., D. E. Brodersen, W. M. Clemons, Jr., R. J. Morgan-Warren, A. P. Carter, C. Vonrhein, T. Hartsch, and V. Ramakrishnan. 2000. Structure of the 30S ribosomal subunit. Nature 407:327-339.
316. Wohlleben, W., W. Arnold, L. Bissonnette, A. Pelletier, A. Tanguay, P. H. Roy, G. C. Gamboa, G. F. Barry, E. Aubert, J. Davies, et al. 1989. On the evolution of Tn21-like multiresistance transposons: sequence analysis of the gene (aacC1) for gentamicin acetyltransferase-3-I (AAC(3)-I), another member of the Tn21-based expression cassette. Mol. Gen. Genet. 217:202-208.
317. Wright, G. D., A. M. Berghuis, and S. Mobashery. 1998. Aminoglycoside antibiotics. Structures, functions, and resistance, p. 27-69. In B. P. Rosen and S. Mobashery (ed.), Resolving the antibiotic paradox: progress in understanding drug resistance and development of new antibiotics. Kluwer Academic/Plenum Publishers, New York. N.Y.
318. Wright, G. D., and P. Ladak. 1997. Overexpression and characterization of the chromosomal aminoglycoside 6′-N-acetyltransferase from Enterococcus faecium. Antimicrob. Agents Chemother. 41:956-960.
319. Wrighton, C. J., and P. Strike. 1987. A pathway for the evolution of the plasmid NTP16 involving the novel kanamycin resistance transposon Tn4352. Plasmid 17:37-45.
320. Yoshizawa, S., D. Fourmy, R. G. Eason, and J. D. Puglisi. 2002. Sequence-specific recognition of the major groove of RNA by deoxystreptamine. Biochemistry 41:6263-6270.
321. Yoshizawa, S., D. Fourmy, and J. D. Puglisi. 1998. Structural origins of gentamicin antibiotic action. EMBO J. 17:6437-6448.
322. You, I., R. Kariyama, M. J. Zervos, H. Kumon, and J. W. Chow. 2000. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 36:37-41.
323. Young, E. J. 1995. An overview of human brucellosis. Clin. Infect. Dis. 21:283-289.
324. Zalacain, M., A. Gonzalez, M. C. Guerrero, R. J. Mattaliano, F. Malpartida, and A. Jimenez. 1986. Nucleotide sequence of the hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. Nucleic Acids Res. 14:1565-1581.
325. Zeng, S., C. Hu, H. Wei, Y. Lu, Y. Zhang, J. Yang, G. Yun, W. Zou, and B. Song. 1993. Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model. Ophthalmology 100:1640-1644.
326. Zhanel, G. G., D. J. Hoban, and G. K. Harding. 1991. The postantibiotic effect: a review of in vitro and in vivo data. Ann. Pharmacother. 25:153-163.